title: Receipt of systemic corticosteroids during asthma visits to US emergency departments, 2007-2009.
abstract: BACKGROUND
  National Asthma Education and Prevention Program recommended emergency department (ED) asthma treatment includes both providing systemic corticosteroids in the ED and a steroid prescription at discharge.
  
  
  OBJECTIVE
  To examine the prevalence of three types of substandard ED asthma care-providing a discharge prescription only, providing corticosteroids in the ED only, and providing neither- and how care varies with exacerbation severity.
  
  
  METHODS
  We used the National Hospital Ambulatory Medical Care Survey-Emergency Department (NHAMCS-ED) (2007, 2008, and 2009) to identify ED asthma visits (International Classification of Diseases-9(th) Revision Clinical Modification (ICD-9-CM codes 493.xx)) for patients aged 1 to <65 years. The primary outcome was the percent of visits receiving each type of substandard care, both overall and by exacerbation severity. Multinomial logistic regressions with predictive margins were used to obtain estimates adjusted for patient, visit, and hospital characteristics.
  
  
  RESULTS
  For 27.1% (confidence interval (CI): 24.0-30.2%) of visits, patients received corticosteroids both in the ED and as a discharge prescription. A discharge prescription only was provided for 12.3% of visits (CI: 10.2-14.6%), corticosteroids were provided in the ED only for 18.2% (CI: 15.6-21.2%), and no corticosteroids were provided for 42.4% (CI: 38.8-46.2%). Even among visits by patients with abnormal overall respiratory status (fast respiratory rates, pulse oximetry values <97%, or both), only 32.3% (CI: 27.8-36.8) were provided corticosteroids both in the ED and as a prescription, while the remainder received some type of substandard care. Adjusted and unadjusted results were similar.
  
  
  CONCLUSIONS
  Substandard ED asthma care is common, even among visits by patients with more severe asthma exacerbations.
authors: Infant, Child, and Women's Health Statistics Branch, Office of Analysis and Epidemiology, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD, USA. fpa8@cdc.gov
authors: Alan E
authors: AE
authors: Simon
authors: Lara J
authors: LJ
authors: Akinbami
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004632:Emergency Medical Services / Q000379:methods*; D004636:Emergency Service, Hospital; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D007223:Infant; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D014481:United States; D055815:Young Adult
chemical_list: D000305:Adrenal Cortex Hormones; D018927:Anti-Asthmatic Agents
references: Natl Health Stat Report. 2010 Aug 6;(26):1-31
references: 20726217
references: J Asthma. 2011 Feb;48(1):69-74
references: 21117877
references: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000195
references: 17636617
references: Ann Pharmacother. 2007 Oct;41(10):1625-31
references: 17848423
references: J Asthma. 2012 Feb;49(1):16-22
references: 22236442
references: Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-247-51
references: 18646359
references: Natl Health Stat Report. 2008 Aug 6;(7):1-38
references: 18958996
references: Vital Health Stat 13. 2011 Apr;(169):1-38
references: 21614897
references: J Allergy Clin Immunol. 2009 Feb;123(2):354-61
references: 19070357
references: Chest. 2003 Oct;124(4):1318-24
references: 14555561
references: NCHS Data Brief. 2012 May;(94):1-8
references: 22617340
references: Vital Health Stat 2. 2012 Jan;(154):1-65
references: 22783637
references: Thorax. 2000 Jul;55(7):566-73
references: 10856316
references: J Asthma. 2003;40(7):741-9
references: 14626330